EntryPoint Capital, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 267 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 3.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
EntryPoint Capital, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$243,549
+26.5%
8,335
+46.1%
0.22%
+17.8%
Q4 2023$192,5205,7060.18%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Tamarack Advisers, LP 273,000$8,818,0006.24%
Standard Investments LLC 775,388$25,045,0004.58%
ARMISTICE CAPITAL, LLC 400,000$12,920,0003.06%
HealthCor Management, L.P. 1,575,000$50,873,0002.88%
DARUMA CAPITAL MANAGEMENT LLC 1,219,642$39,394,0002.24%
Consonance Capital Management LP 631,805$20,407,0002.24%
Rock Springs Capital Management LP 713,000$23,030,0001.54%
Biondo Investment Advisors, LLC 142,473$4,602,0001.52%
Opus Point Partners Management, LLC 50,000$1,615,0001.29%
Partner Investment Management, L.P. 26,690$862,0001.14%
View complete list of PACIRA PHARMACEUTICALS INC shareholders